메뉴 건너뛰기




Volumn 23, Issue 5, 2003, Pages 522-523

Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment [3]

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; GABAPENTIN; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

EID: 0141817113     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000088917.02635.7a     Document Type: Letter
Times cited : (14)

References (8)
  • 1
    • 0031969105 scopus 로고    scopus 로고
    • Reducing clozapine-related morbidity and mortality: 5 Years of experience with the Clozaril National Registry
    • Honigfeld G, Arellano F, Sethi J, et al. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psychiatry. 1998;59(suppl 3):3-7.
    • (1998) J Clin Psychiatry , vol.59 , Issue.SUPPL. 3 , pp. 3-7
    • Honigfeld, G.1    Arellano, F.2    Sethi, J.3
  • 2
    • 0027238608 scopus 로고
    • Clozapine-induced agranulocytosis. Incidence and risk factors in the United States
    • Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med. 1993;329:162-167.
    • (1993) N Engl J Med , vol.329 , pp. 162-167
    • Alvir, J.M.1    Lieberman, J.A.2    Safferman, A.Z.3
  • 3
    • 0033288769 scopus 로고    scopus 로고
    • Active monitoring of 12,760 clozapine recipients in the UK and Ireland-beyond pharmacovigilance
    • Munro J, O'Sullivan D, Andrews C, et al. Active monitoring of 12,760 clozapine recipients in the UK and Ireland-beyond pharmacovigilance. Br J Psychiatry. 1999;175:576-580.
    • (1999) Br J Psychiatry , vol.175 , pp. 576-580
    • Munro, J.1    O'Sullivan, D.2    Andrews, C.3
  • 4
    • 0034795538 scopus 로고    scopus 로고
    • Late onset neutropenia during clozapine treatment
    • Tamam L, Kulan E, Ozpoyraz N. Late onset neutropenia during clozapine treatment [letter]. Psychiatry Clin Neurosci. 2001;55:547-548.
    • (2001) Psychiatry Clin Neurosci , vol.55 , pp. 547-548
    • Tamam, L.1    Kulan, E.2    Ozpoyraz, N.3
  • 5
    • 0141603878 scopus 로고    scopus 로고
    • Quetiapine augmentation for inadequate response to combination atypical antipsychotics
    • October 10-14, Orlando, Florida, Poster 51
    • Chouinard G, Margolese HC, Kolivakis TT, et al. Quetiapine augmentation for inadequate response to combination atypical antipsychotics. In: Book of abstracts of the 53rd APA Institute on Psychiatric Services, October 10-14 2001, Orlando, Florida, Poster 51, pp. 96-97.
    • (2001) Book of Abstracts, 53rd APA Institute on Psychiatric Services , pp. 96-97
    • Chouinard, G.1    Margolese, H.C.2    Kolivakis, T.T.3
  • 6
    • 0034807482 scopus 로고    scopus 로고
    • Agranulocytosis and granulocytopenia associated with quetiapine
    • Ruhé HG, Becker HE, Jessurun P, et al. Agranulocytosis and granulocytopenia associated with quetiapine. Acta Psychiatr Scand. 2001;104:311-314.
    • (2001) Acta Psychiatr Scand , vol.104 , pp. 311-314
    • Ruhé, H.G.1    Becker, H.E.2    Jessurun, P.3
  • 7
    • 20644472010 scopus 로고    scopus 로고
    • Genetic factors in clozapine-induced agranulocytosis
    • Reznik I, Mester R. Genetic factors in clozapine-induced agranulocytosis. Israel Med Assoc J. 2000;2:857-858.
    • (2000) Israel Med Assoc J , vol.2 , pp. 857-858
    • Reznik, I.1    Mester, R.2
  • 8
    • 0035175936 scopus 로고    scopus 로고
    • Genetic determinants of clozapine-induced agranulocytosis: Recent results of HLA subtyping in a non-Jewish Caucasian sample
    • Dettling M, Cascorbi I, Roots I, et al. Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-Jewish Caucasian sample. Arch Gen Psychiatry. 2001;58:93-94.
    • (2001) Arch Gen Psychiatry , vol.58 , pp. 93-94
    • Dettling, M.1    Cascorbi, I.2    Roots, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.